Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2003 Aug;89 Suppl 1(Suppl 1):S59-66.
doi: 10.1038/sj.bjc.6601085.

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)

R Bugat  1 , A Bataillard, T Lesimple, J J Voigt, S Culine, A Lortholary, Y Merrouche, G Ganem, M C Kaminsky, S Negrier, M Perol, C Laforêt, P Bedossa, G Bertrand, J M Coindre, K Fizazi; FNCLCC
Affiliations
Guideline

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)

R Bugat et al. Br J Cancer. 2003 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
First diagnostic step for carcinoma of unknown primary site.
Figure 2
Figure 2
Histopathological diagnosis for carcinoma of unknown primary site.
Figure 3
Figure 3
Histopathological diagnosis of undifferentiated carcinoma and adenocarcinoma.
Figure 4
Figure 4
Second diagnostic step for adenocarcinoma and undifferentiated carcinoma.
Figure 5
Figure 5
Third diagnostic step for adenocarcinoma and undifferentiated carcinoma.
Figure 6
Figure 6
Complementary examinations for squamous cell carcinoma.
Figure 7
Figure 7
Treatment of neuroendocrine carcinoma.
Figure 8
Figure 8
Treatment of cervical lymph node metastases in patients with squamous cell carcinoma.
Figure 9
Figure 9
Treatment of axillary lymph node metastases in patients with adenocarcinoma.
Figure 10
Figure 10
General treatment of carcinoma of unknown primary site not belonging to a specific anatomoclinical entity.
See this image and copyright information in PMC

References

    1. Bugat R, Bataillard A, Lesimple T, Voigt JJ, Culine S, Lortholary A, Merrouche Y, Ganem G, Kaminsky MC, Negrier S, Perol M, Laforet C, Bedossa P, Bertrand G, Coindre JM, Fizazi K (2002) Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site. Bull Cancer 89: 869–875 - PubMed
    1. Fervers B, Hardy J, Blanc-Vincent MP, Theobald S, Bataillard A, Farsi F, Gory G, Debuiche S, Guillo S, Renaud-Salis JL, Pinkerton R, Bey P, Philip T (2001) SOR: project methodology. Br J Cancer 84 (Suppl 2), 8–16 - PMC - PubMed